Lipoproteins and coronary artery disease.
Although a great deal has been learned about HDL as a protective factor, our understanding of the role of HDL is far less comprehensive than that of LDL. Until such knowledge is available, efforts directed at altering HDL levels must be tentative and subject to revision, as indicated by experience. There is no evidence to warrant the use of drugs whose primary effect is to raise HDL.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000209:etiology* / Q000628:therapy; D004032:Diet; D005260:Female; D006801:Humans; D007223:Infant; D008074:Lipoproteins / Q000378:metabolism* / Q000502:physiology; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D012306:Risk
D000924:Anticholesteremic Agents; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D002784:Cholesterol